Pharmaceutical Commerce

Pharmaceutical Commerce is a publication aimed at biopharma executives who make key business decisions. It highlights the processes and technologies that play a role in bringing approved drugs to market. Our editorial content is designed to enhance teamwork among management professionals, ultimately aiming to lower the costs associated with commercial operations.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#1895227

United States

#766329

Health/Biotechnology and Pharmaceuticals

#734

Traffic sources

Monthly visitors

Articles

President Trump Announces Most-Favored-Nation Policy for Pharma Prices

4 days ago | pharmaceuticalcommerce.com | Michael Hollan

On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for pharmaceutical drug prices.
Pharma Pulse 5/12/25: FDA Chief Martin Makary Sets June Deadline for GenAI Rollout, Moderna’s Flu-COVID Vaccine Beats Standard Shots

5 days ago | pharmaceuticalcommerce.com | Don Tracy

FDA chief Martin Makary sets June deadline for genAI rolloutFDA Commissioner Martin Makary has set a June 30, 2025 deadline for full agency-wide rollout of generative AI to streamline scientific reviews and reduce bureaucratic workload, amid concerns about whether the technology can offset recent staffing cuts under HHS Secretary Robert F.
Is the Industry Ready for the DSCSA?

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the HDA Distribution Management Conference (DMC) covers a broad spectrum of topics within the pharmaceutical supply chain, with a special focus on current regulatory and operational challenges. One of the major topics at this year’s conference was the Drug Supply Chain Security Act (DSCSA), which prompted several discussions and roundtable sessions.
Antares Vision Group, Siempharma Strike Up Pharma Labeling Equipment Collaboration

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

Antares Vision Group, a provider of track-and-trace systems for several fields including the life sciences, is growing its solutions portfolio to now include precision labeling equipment. The company is collaborating with Siempharma, a manufacturer of packaging machines, by welcoming the ETF-300.1This machine is capable of working with containers ranging from 40-180 mm in height, and 22-80 mm in diameter. It can apply labels as tall as 100 mm at speeds of up to 80 meters per minute.
Pharma Pulse 5/8/2025: J&J Survey Finds Pace of Oncology Innovation is Overwhelming Physicians, Biotech is Guessing How Vinay Prasad Might Change the FDA

1 week ago | pharmaceuticalcommerce.com | Don Tracy

J&J survey finds pace of oncology innovation is overwhelming physiciansA recent J&J survey reveals that oncologists are overwhelmed by the rapid pace of oncology innovation, highlighting the need for additional support and continuing medical education to help them keep up with new treatments and guidelines. Biotech is guessing how Vinay Prasad might change the FDA.
Key Takeaways From the 2025 HDA Distribution Management Conference

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the HDA Distribution Management Conference (DMC) covers a broad spectrum of topics within the pharmaceutical supply chain, with a special focus on current regulatory and operational challenges. One of the major topics at this year’s conference was the Drug Supply Chain Security Act (DSCSA), which prompted several discussions and roundtable sessions.
Asembia 2025: Tracking Long-Term Outcomes Key to Advanced Therapy Value

1 week ago | pharmaceuticalcommerce.com | Don Tracy

In an interview with Pharmaceutical Commerce, Fran Gregory, VP, emerging therapies, Cardinal Health, shared key insights into the evolving landscape of cell and gene therapies. Speaking about the current state of the market, the anticipated growth of the pipeline, and the critical steps needed to ensure long-term sustainability, Gregory highlighted both the transformative potential of these therapies and the systemic challenges that must be addressed.
Pharma Pulse 5/5/25: Deerfield Secures More than $600 Million for Next Biotech Venture Fund; What is The Hardest Job in Biopharma?

1 week ago | pharmaceuticalcommerce.com | Don Tracy

Deerfield secures more than $600M for its next biotech venture fundDeerfield Management has raised over $600 million for its third biotech venture fund to invest in early-stage healthcare companies, leveraging its NYC-based Cure campus and academic partnerships amid a broader industry shift toward larger, more selective funding rounds. The Hardest Job in Biopharma?
Asembia 2025: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes

2 weeks ago | pharmaceuticalcommerce.com | Don Tracy

The second day of Asembia’s AXS25 Summit featured a session that addressed a distinct set of challenges facing the pharmaceutical industry. Titled “Beyond the Headlines: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes,” the discussion highlighted how evolving global instability, policy shifts, and supply chain vulnerabilities are reshaping access and strategy within the US healthcare system.
Asembia 2025: The Cost of Care for Patients

2 weeks ago | pharmaceuticalcommerce.com | Nicholas Saraceno

The afternoon sessions here on day 3 of Asembia continued its impressive slate, with its various business seminars as proof.